Sarcopenic ObesityNCT07523672
Effectiveness of a Care Model for Sarcopenic Obesity in Older Adults on Fat Mass, Muscle Mass, Muscle Strength, and Physical Performance
A study testing sarcopenic obesity modification programe in people with Sarcopenic Obesity, run by Srinakharinwirot University at 1 site in Thailand.
Trial summary
Older adults Read more about this study
- Who is it for?
- Ages 60 years and olderHealthy volunteers can take part
- Conditions the study is for
- Sarcopenic Obesity
- What is being tested?
- sarcopenic obesity modification programe
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 66 participants
- Where
- 1 siteThailand
- Study dates
- 4 Jul 2025to 1 Aug 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Diagnosis with sarcopenic obesity
- obesity followed by WHO criteria for asian (BMI >25 kg/m2)
- sarcopenia followed by Asian Working Group of Sarcopenia (AWGS)
Who cannot join
- Heart disease
- renal disease
- cancer with active treatment
- other disease that may effect muscle mass
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Thailand1 site
Faculty of Nursing, Srinakharinwirot University
Nakhon Nayok, Changwat Nakhon Nayok, 26000
About this study
Older adults
Read the detailed description
Sarcopenic obesity rehabilitation and health behaviors modification will delivered to older adults with sarcopenic obesity
- Conditions
- Sarcopenic Obesity
- Being tested
- sarcopenic obesity modification programe
- Keywords
- sarcopenic obesity, older adults, care model
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
sarcopenic obesity modification programeBehavioural
Subjects received health intervention for improve sarcopenic obesity including diet and exercise
| Study group | Role | What they receive |
|---|---|---|
| Control group | Active comparator | Subjects received usual care, if they have any health problems they will be meet the doctors Receives: Behavioral: sarcopenic obesity modification programe |
What is being measured
The primary outcome is the main question the study is designed to answer.
Body fat
Body fat percentage of each subject (%)
Measured: 16 weeks
Muscle mass
Skeletal muscle index (SMI) (kilogram/m^2)
Measured: 16 weeks
Physical performance
5 time sit-stand (seconds)
Measured: 16 weeks
Physical performance2
6 meters walk (seconds)
Measured: 16 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Apr 2026
- Study start4 Jul 2025
- Primary completion1 Aug 2026 (estimated)
- Study completion1 Aug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sarcopenic ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Sequential
- Model description
- 1. Control group received usual care 2. Experimental group received health modification intervention
- Masking
- None (open label)
- Enrolment
- 66 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Srinakharinwirot University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Nuchthida Samaisong, Srinakharinwirot University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07523672
- Sponsor's protocol ID
- Sarcopenic obesity
- Status last verified
- Jul 2026
- First submitted
- 31 Mar 2026
- Last updated
- 21 Jul 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of a Care Model for Sarcopenic Obesity in Older Adults on Fat Mass, Muscle Mass, Muscle Strength, and Physical Performance
- ClinicalTrials.gov ID
- NCT07523672
- Acronym / sponsor ID
- Sarcopenic obesity
- Conditions
- Sarcopenic Obesity
- Keywords
- sarcopenic obesity, older adults, care model
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 66 participants (estimated)
- Lead sponsor
- Srinakharinwirot UniversityUniversity, hospital or other
- Study start
- 4 Jul 2025 (actual)
- Primary completion
- 1 Aug 2026 (estimated)
- Study completion
- 1 Aug 2026 (estimated)
- First posted
- 13 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Older adults
Detailed description
Sarcopenic obesity rehabilitation and health behaviors modification will delivered to older adults with sarcopenic obesity
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Sequential
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- 1. Control group received usual care 2. Experimental group received health modification intervention
| Arm | Type | Receives |
|---|---|---|
| Control group | Active comparator | Behavioral: sarcopenic obesity modification programeSubjects received usual care, if they have any health problems they will be meet the doctors |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Diagnosis with sarcopenic obesity
- obesity followed by WHO criteria for asian (BMI >25 kg/m2)
- sarcopenia followed by Asian Working Group of Sarcopenia (AWGS)
Key exclusion criteria (4 listed)
- Heart disease
- renal disease
- cancer with active treatment
- other disease that may effect muscle mass
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| sarcopenic obesity modification programeSubjects received health intervention for improve sarcopenic obesity including diet and exercise | Behavioural | Control group |
Primary outcome
Body fat
Time frame: 16 weeks
Body fat percentage of each subject (%)
Muscle mass
Time frame: 16 weeks
Skeletal muscle index (SMI) (kilogram/m^2)
Physical performance
Time frame: 16 weeks
5 time sit-stand (seconds)
Physical performance2
Time frame: 16 weeks
6 meters walk (seconds)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jul 2026.
- Individual participant dataSharing planned: No
Related trials for Sarcopenic Obesity
RecruitingObservational study
Effects of Obesity on Physical Abilities and Daily Living Activities in Elderly Adults
Obesity, Sarcopenic Obesity
Active, not recruitingObservational study
Dietary Intake, Sarcopenic Obesity, and Other Treatment-Related Outcomes in Indian Children With Acute Lymphoblastic Leukemia
Sarcopenic Obesity
RecruitingObservational study
Investigating the Link Between Advanced Glycation End Products (AGEs) and Muscle Wasting in Sarcobesity
Sarcopenia, Obesity
Not yet recruiting
Effects of the EatWelLog App on Enhancing Diet Management for Older Adults With Sarcopenic Obesity
Sacropenic Obesity
RecruitingObservational study
GLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without Diabetes
Obesity, Sarcopenia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing sarcopenic obesity modification programe in people with Sarcopenic Obesity, run by Srinakharinwirot University at 1 site in Thailand.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 21 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Body fat (time frame: 16 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2026.